We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $615M invested in Meridian Bioscience Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $281K

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

14% more capital invested

Capital invested by funds: $541M → $615M (+$74.1M)

5% less funds holding

Funds holding: 186 → 177 (-9)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
69
Reduced
49
Closed
22
Calls
$2.13M
Puts
$281K
Net Calls
+$1.85M
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.74M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.05M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.29M
4
SBH
Segall Bryant & Hamill
Illinois
+$3.16M
5
Invesco
Invesco
Georgia
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.9M
2
BCM
Brown Capital Management
Maryland
-$5.14M
3
Rafferty Asset Management
Rafferty Asset Management
New York
-$4.43M
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$3.25M
5
Prudential Financial
Prudential Financial
New Jersey
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
151
US Bancorp
Minnesota
$22K -$24.8K -1,662 -54%
HS
152
Horan Securities
United States
$21K +$179 +12 +0.9%
PCM
153
Prelude Capital Management
New York
$19K -$77.7K -5,211 -81%
VCM
154
Versant Capital Management
Arizona
$19K -$3.15K -211 -15%
GT
155
Glenmede Trust
Pennsylvania
$19K -$3.13K -210 -15%
LTFS
156
Ladenburg Thalmann Financial Services
Florida
$16K – – –
QT
157
Quantbot Technologies
New York
$14K -$7.46K -500 -36%
RWP
158
RWA Wealth Partners
Massachusetts
$13K +$12.6K +844 New
MAM
159
Meeder Asset Management
Ohio
$12.7K – – –
CF
160
Centaurus Financial
California
$10K +$8.95K +600 New
TFS
161
TrustCore Financial Services
Tennessee
$9K – – –
Federated Hermes
162
Federated Hermes
Pennsylvania
$8K +$7.29K +489 New
FGAM
163
Financial Gravity Asset Management
Texas
$7K +$3.4K +228 +107%
WAP
164
Wealthcare Advisory Partners
Pennsylvania
$5K +$45 +3 +0.9%
Envestnet Asset Management
165
Envestnet Asset Management
Illinois
$4K – – –
WAM
166
Wealthspire Advisors (Maryland)
Maryland
$4K – – –
Carson Wealth (CWM LLC)
167
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
PSC
168
Prentiss Smith & Co
Vermont
$3K – – –
SPIA
169
Steward Partners Investment Advisory
New York
$3K – – –
SEI Investments
170
SEI Investments
Pennsylvania
$2K -$1.28K -86 -45%
OFW
171
Omnia Family Wealth
Florida
$2K – – –
PA
172
Parallel Advisors
California
$2K – – –
JA
173
JOYN Advisors
Georgia
$2K +$1.77K +119 New
MOACM
174
Mutual of America Capital Management
New York
$2K +$2.33K +156 New
PFBT
175
Parkside Financial Bank & Trust
Missouri
$1K – – –
4 5 6
7
8

VIVO Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2018, worth a combined $615M — up 14% from $541M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVO and 16 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was BlackRock, adding an estimated $7.74M. The largest seller was Millennium Management, cutting an estimated $5.9M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2018, down from 186 in Q1 2018.
  • Funds reported $615M of Meridian Bioscience Inc stock for Q2 2018, up 14% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q2 2018 and 22 closed out, a net change of -6 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2018 was BlackRock, an estimated $7.74M added.
  • The largest Meridian Bioscience Inc seller in Q2 2018 was Millennium Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q2 2018.